Dr. Tammy Nowling is an Assistant Professor in the Division of Rheumatology at the Medical University of South Carolina. She received a BA in Biology and in Chemistry at the University of Northern Iowa and her Ph.D. in Molecular, Cellular and Developmental Biology at Iowa State University in 1996. She held a postdoctoral position from 1996 to 2003 at the Eppley Cancer Institute at the University of Nebraska Medical Center before coming to the Medical University of South Carolina.
Dr. Nowling’s research interests focus on the transcriptional regulation of genes involved in the immune system and the progression of systemic lupus erythematosus (SLE or lupus) and other autoimmune diseases. Current projects in her laboratory are focused on understanding how the Fli1 gene is regulated in healthy lymphocytes and misregulated in disease lymphocytes and the role of Fli1 in the progression of disease. One long-term goal of her laboratory is to target Fli1 or other factors in the Fli1 regulatory pathway as a therapeutic treatment for lupus patients. Dr. Nowling is the principal investigator on NIH K01 and R03 awards. She is a member of the Women Scholar’s Initiative Networking Committee at MUSC and serves as a reviewer on the Molecular Biology study section for the Arthritis Foundation.
installed on your computer. 